Rtw Investments, LP Rocket Pharmaceuticals, Inc. Call Options Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RCKT
# of Institutions
243Shares Held
94.3MCall Options Held
262KPut Options Held
159K-
Vanguard Group Inc Valley Forge, PA6.58MShares$50.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$47.6 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$40 Million1.26% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$36.3 Million0.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.12MShares$31.7 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $582M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...